Nivolumab,Relatlimab
BMS
['melanoma']
it s finally #melanomamonday at #asco23! come join us at 3pm in hall d1 for the melanoma oral abstract session. exciting data to come today from my colleagues zeynep eroglu et al. 
Director of Melanoma Program, Oncology Director of Solid Tumor Cell Therapy @StanfordCancer | FCOI: https://t.co/BQzZa9DdO7…